Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Syphilis
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 
 
 

Self-Study STD Module - Syphilis

Partner Management and Public Health Measures

Partner Management

Sexual transmission of T. pallidum occurs only when mucocutaneous syphilitic lesions are present; such manifestations are uncommon after the first year of infection. However, these lesions may be clinically inapparent. Persons sexually exposed to a person with syphilis in any stage should be evaluated clinically and serologically.

At-risk sex partners are determined based on the patient's diagnosed stage of disease. Partners exposed during the following time periods before the patient recieves treatment should be considered at-risk:

  Primary: 3 months plus duration of symptoms
Secondary: 6 months plus duration of symptoms
Early latent: 1 year

Presumptive treatment should be given to those persons who were exposed within the 90 days preceding a sex partner's diagnosis of primary, secondary, or early latent syphilis, because they might be infected, even if seronegative.

Persons who were exposed >90 days before a sex partner's diagnosis of primary, secondary, or early latent syphilis should also be treated presumptively if serologic test results are not available immediately and the opportunity for follow-up is uncertain.

For purposes of partner notification and presumptive treatment of exposed sex partners, patients with syphilis of unknown duration who have high nontreponemal serologic test titers (i.e., >1:32) may be considered as having early syphilis. However, serologic titers should not be used to differentiate early from late latent syphilis for the purpose of determining treatment.

Long-term sex partners of patients who have latent syphilis should be evaluated clinically and serologically for syphilis and treated on the basis of the findings of the evaluation.

 
Click here for a Study Question

Reporting and Public Health Follow Up

Patients with primary, secondary or early latent syphilis, or syphilis of unknown duration with a high nontreponemal serologic test titer (i.e., >1:32), should be referred to the local health department STD program for interview, partner elicitation, and partner follow up. The follow up of patients with early syphilis is a public health priority. Laws and regulations in all states require that persons diagnosed with syphilis be reported to public health authorities. Reporting can be provider or laboratory based. Providers unsure of reporting requirements should seek advice from state or local health departments or STD Programs.  Click here for links to state and local public health departments.

Screening

  • Pregnant women should be screened and counseled at least at the first prenatal visit.
    • For communities and populations in which the prevalence of syphilis is high, or for patients at risk, serologic testing should be performed twice during the third trimester, at 28 weeks, and at delivery, in addition to routine early screening.
    • Any woman who gives birth to a stillborn infant after 20 weeks gestation should be tested for syphilis.
    • No infant should leave the hospital without the maternal serologic status having been determined at least once during pregnancy and preferably again at delivery.
  • Other populations should be selected for screening based on local prevalence of syphilis and the patient’s risk behaviors.
  • Contact your state/local health department for populations at risk and for screening recommendations in your area.
 
 
Page 16 of 19 BackStatusStatusNext
Page last modified: June 3, 2009
Page last reviewed: June 3, 2009

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention